Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk Score for Predicting In-Hospital Mortality in COVID-19 (RIM Score).
López-Escobar A, Madurga R, Castellano JM, Velázquez S, Suárez Del Villar R, Menéndez J, Peixoto A, Jimeno S, Ventura PS, Ruiz de Aguiar S. López-Escobar A, et al. Among authors: madurga r. Diagnostics (Basel). 2021 Mar 26;11(4):596. doi: 10.3390/diagnostics11040596. Diagnostics (Basel). 2021. PMID: 33810534 Free PMC article.
Hemogram as marker of in-hospital mortality in COVID-19.
López-Escobar A, Madurga R, Castellano JM, Ruiz de Aguiar S, Velázquez S, Bucar M, Jimeno S, Ventura PS. López-Escobar A, et al. Among authors: madurga r. J Investig Med. 2021 Jun;69(5):962-969. doi: 10.1136/jim-2021-001810. Epub 2021 Apr 13. J Investig Med. 2021. PMID: 33849952
Hemogram-derived ratios as prognostic markers of ICU admission in COVID-19.
Velazquez S, Madurga R, Castellano JM, Rodriguez-Pascual J, de Aguiar Diaz Obregon SR, Jimeno S, Montero JI, Wichner PSV, López-Escobar A. Velazquez S, et al. Among authors: madurga r. BMC Emerg Med. 2021 Jul 27;21(1):89. doi: 10.1186/s12873-021-00480-w. BMC Emerg Med. 2021. PMID: 34315437 Free PMC article.
Early detection of anthracycline- and trastuzumab-induced cardiotoxicity: value and optimal timing of serum biomarkers and echocardiographic parameters.
Díaz-Antón B, Madurga R, Zorita B, Wasniewski S, Moreno-Arciniegas A, López-Melgar B, Ramírez Merino N, Martín-Asenjo R, Barrio P, Amado Escañuela MG, Solís J, Parra Jiménez FJ, Ciruelos E, Castellano JM, Fernández-Friera L. Díaz-Antón B, et al. Among authors: madurga r. ESC Heart Fail. 2022 Apr;9(2):1127-1137. doi: 10.1002/ehf2.13782. Epub 2022 Feb 2. ESC Heart Fail. 2022. PMID: 35106939 Free PMC article.
Randomized phase II clinical trial of ruxolitinib plus simvastatin in COVID19 clinical outcome and cytokine evolution.
Garcia-Donas J, Martínez-Urbistondo D, Velázquez Kennedy K, Villares P, Barquin A, Dominguez A, Rodriguez-Moreno JF, Caro E, Suarez Del Villar R, Nistal-Villan E, Yagüe M, Ortiz M, Barba M, Ruiz-Llorente S, Quiralte M, Zanin M, Rodríguez C, Navarro P, Berraondo P, Madurga R. Garcia-Donas J, et al. Among authors: madurga r. Front Immunol. 2023 Apr 18;14:1156603. doi: 10.3389/fimmu.2023.1156603. eCollection 2023. Front Immunol. 2023. PMID: 37143685 Free PMC article. Clinical Trial.
Application of pelvic floor ultrasound during pregnancy to detect patients at risk of cesarean section due to failure of labor progression in a Spanish population.
Guntiñas A, Galocha C, Madurga R, Kirk J, Usandizaga R, Ángel Rodríguez-Zambrano M. Guntiñas A, et al. Among authors: madurga r. Eur J Obstet Gynecol Reprod Biol. 2022 Feb;269:102-107. doi: 10.1016/j.ejogrb.2021.12.025. Epub 2021 Dec 27. Eur J Obstet Gynecol Reprod Biol. 2022. PMID: 34979363 Free article.
Case-control study assessing the impact of COVID19 in advanced kidney cancer patients treated with antiangiogenics or immunotherapy: the COVID-REN study.
García-Donas J, de Velasco G, Madurga R, Chamorro J, Rosero D, Etxaniz O, Pérez-Gracia JL, Pinto Á, Cacho D, Barba M, Borrega P, Lázaro M, Rodriguez L, Villalobos L, García L, Cuellar A, Solís-Hernández MP, González A, Pernaut C, Rodríguez-Moreno JF. García-Donas J, et al. Among authors: madurga r. Clin Transl Oncol. 2024 Mar;26(3):732-738. doi: 10.1007/s12094-023-03295-2. Epub 2023 Aug 9. Clin Transl Oncol. 2024. PMID: 37556096
Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma.
García-Romero N, Palacín-Aliana I, Madurga R, Carrión-Navarro J, Esteban-Rubio S, Jiménez B, Collazo A, Pérez-Rodríguez F, Ortiz de Mendivil A, Fernández-Carballal C, García-Duque S, Diamantopoulos-Fernández J, Belda-Iniesta C, Prat-Acín R, Sánchez-Gómez P, Calvo E, Ayuso-Sacido A. García-Romero N, et al. Among authors: madurga r. BMC Med. 2020 Jun 22;18(1):142. doi: 10.1186/s12916-020-01610-0. BMC Med. 2020. PMID: 32564774 Free PMC article.
27 results